HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oncostatin M expression and TP53 mutation status regulate tumor-infiltration of immune cells and survival outcomes in cholangiocarcinoma.

Abstract
In this study, we used bioinformatics tools to analyze transcriptome data from cholangiocarcinoma (CCA) patients in multiple datasets (Sun Yat-sen University, TCGA and GSE32225 cohorts) to identify mechanisms that regulate tumor infiltration by immune cells and survival outcomes. We identified 96 differentially expressed genes (DEGs), including 13 upregulated and 83 downregulated genes, in CCA tissues as regulatory T cells were significantly higher and the proportions of activated natural killer cells and monocytes were significantly lower in CCA tissues than the precancerous tissues. The survival outcomes of CCA patients were associated with the TP53 gene mutation status, levels of Oncostatin M (OSM) expression, and the proportions of tumor-infiltrating immune cell types, including dendritic cells, monocytes, and T follicular helper cells. Functional enrichment analysis of the DEGs in the high OSM-expressing CCA tissues showed that pathways related to tumor progression and immune response were significantly upregulated. Our study demonstrates that OSM expression and TP53 mutation status regulate the tumor infiltration by immune cells and survival outcomes in CCA. OSM is thus a potential prognostic biomarker and therapeutic target in cholangiocarcinoma.
AuthorsQi Liu, Tian Lan, Yuxuan Song, Jianpeng Cai, Xi Yu, Wei Chen
JournalAging (Aging (Albany NY)) Vol. 12 Issue 21 Pg. 21518-21543 (11 07 2020) ISSN: 1945-4589 [Electronic] United States
PMID33216732 (Publication Type: Journal Article)
Chemical References
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Oncostatin M
Topics
  • Bile Duct Neoplasms (genetics, immunology, mortality)
  • Cholangiocarcinoma (genetics, immunology, mortality)
  • Computational Biology
  • Gene Expression Profiling
  • Humans
  • Lymphocytes, Tumor-Infiltrating (immunology, metabolism)
  • Oncostatin M (biosynthesis)
  • Prognosis
  • Tumor Suppressor Protein p53 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: